Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

Thomas Smith, an analyst from Leerink Partners, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The ...

Palantir’s multi-decade prowess in advanced mission-critical analytics is already making its AI genuinely valuable. Read why ...

California voters rejected the anti-slavery measure Proposition 6, which would have banned forced labor in state prisons.

Let’s take concrete action to protect the millions of US residents facing the threat of Trump’s deportation crosshairs.

With both, Morocco has always been constant and consistent on the pressing need to translate commitment into concrete action, ...

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

In 2024, the agency built on its strong foundations by welcoming 17 new clients, including the likes of the ABC, Dan Murphy’s and Microsoft. All told, the agency grew its revenue by nearly half over ...

Indians are ambitious and self-confident today. There’s a palpable air of hope and optimism all over the country. Thousands of Adanis and Ambanis are in the making. Driven by a diverse population, a ...

By Ben Aris in Berlin A pall of anticipated disappointment hangs over the COP29 UN climate summit that kicks off in Baku, the ...

Nissan has announced a major restructuring plan in response to mounting financial losses, including the elimination of 9,000 jobs from its global workforce and a 20% reduction in production capacity.